Literature DB >> 23893323

An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.

Inge Anita Meijer1, Michel Vanasse, Sonia Nizard, Yves Robitaille, Elsa Rossignol.   

Abstract

INTRODUCTION: Erythromelalgia due to heterozygous gain-of-function SCN9A mutations usually presents as a pure sensory-autonomic disorder characterized by recurrent episodes of burning pain and redness of the extremities.
METHODS: We describe a patient with an unusual phenotypic presentation of gross motor delay, childhood-onset erythromelalgia, extreme visceral pain episodes, hypesthesia, and self-mutilation. The investigation of the patient's motor delay included various biochemical analyses, a comparative genomic hybridization array (CGH), electromyogram (EMG), and muscle biopsy. Once erythromelalgia was suspected clinically, the SCN9A gene was sequenced.
RESULTS: The EMG, CGH, and biochemical tests were negative. The biopsy showed an axonal neuropathy and neurogenic atrophy. Sequencing of SCN9A revealed a heterozygous missense mutation in exon 7; p.I234T.
CONCLUSIONS: This is a case of global motor delay and erythromelalgia associated with SCN9A. The motor delay may be attributed to the extreme pain episodes or to a developmental perturbation of proprioceptive inputs.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Nav1.7; SCN9A; axonal neuropathy; developmental delay; erythromelalgia; pain

Mesh:

Substances:

Year:  2013        PMID: 23893323     DOI: 10.1002/mus.23968

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Altered Global mRNA Expressions of Pain and Aggression Related Genes in the Blood of Children with Autism Spectrum Disorders.

Authors:  Elif Funda Sener; Serpil Taheri; Mustafa Caglar Sahin; Keziban Korkmaz Bayramov; Mert Kahraman Marasli; Gokmen Zararsiz; Ecmel Mehmetbeyoglu; Didem Behice Oztop; Mehmet Canpolat; Halit Canatan; Yusuf Ozkul
Journal:  J Mol Neurosci       Date:  2018-12-05       Impact factor: 3.444

2.  Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Nav 1.7 mutation I234T.

Authors:  Yang Yang; Talia Adi; Philip R Effraim; Lubin Chen; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Br J Pharmacol       Date:  2017-07-30       Impact factor: 8.739

3.  The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy.

Authors:  Chongyang Han; Andreas C Themistocleous; Mark Estacion; Fadia B Dib-Hajj; Iulia Blesneac; Lawrence Macala; Carl Fratter; David L Bennett; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Mol Pharmacol       Date:  2018-08-22       Impact factor: 4.436

4.  Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy.

Authors:  Julie I R Labau; Mark Estacion; Brian S Tanaka; Bianca T A de Greef; Janneke G J Hoeijmakers; Margot Geerts; Monique M Gerrits; Hubert J M Smeets; Catharina G Faber; Ingemar S J Merkies; Giuseppe Lauria; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

Review 5.  Primary erythromelalgia: a review.

Authors:  Zhaoli Tang; Zhao Chen; Beisha Tang; Hong Jiang
Journal:  Orphanet J Rare Dis       Date:  2015-09-30       Impact factor: 4.123

6.  Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease.

Authors:  Arash Hossein-Nezhad; Roya Pedram Fatemi; Rili Ahmad; Elaine R Peskind; Cyrus P Zabetian; Shu-Ching Hu; Min Shi; Claes Wahlestedt; Jing Zhang; Mohammad Ali Faghihi
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

7.  Atypical changes in DRG neuron excitability and complex pain phenotype associated with a Nav1.7 mutation that massively hyperpolarizes activation.

Authors:  Jianying Huang; Malgorzata A Mis; Brian Tanaka; Talia Adi; Mark Estacion; Shujun Liu; Suellen Walker; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.